15.6 C
Sunday, June 23, 2024

Where Alnylam Pharmaceuticals Stands With Analysts – Alnylam Pharmaceuticals (NASDAQ:ALNY)

Must read

- Advertisement -

Alnylam Pharmaceuticals ALNY has observed the following analyst ratings within the last quarter:

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 10 3 4 0 0
Last 30D 1 1 0 0 0
1M Ago 2 0 1 0 0
2M Ago 0 1 1 0 0
3M Ago 7 1 2 0 0

These 17 analysts have an average price target of $266.88 versus the current price of Alnylam Pharmaceuticals at $205.39, implying upside.

Below is a summary of how these 17 analysts rated Alnylam Pharmaceuticals over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the more negative analysts are on the stock

This current average has increased by 13.15% from the previous average price target of $235.86.

- Advertisement -

Stay up to date on Alnylam Pharmaceuticals analyst ratings.

Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.

Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

- Advertisement -

Source link

- Advertisement -

More articles


Please enter your comment!
Please enter your name here

Latest article